| Blackwell, Kim (Tempus Labs 202009 CMO) |
Chief Medical Officer (CMO) |
Tempus (Group) |
United States (USA) |
| Blain, David (Reinnervate 200709– CFO) |
Chief Financial Officer (CFO) |
ReproCell (Group) |
United Kingdom (GB) |
| Blair, Rainer M. (Danaher 2022 CEO before EVP Life Sciences + Head Life Sciences + AB Sciex + Videojet + MAPEI + BASF) |
President/Director/Head Business Group/Unit/Division |
Danaher (Group) |
United States (USA) |
| Blanarik, Ivan (Boehringer 201707 SVP + Head Therapeutic Area Biosimilars) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Germany |
| Blanc, Antony (CureVac 202012– CBO + CCO before McKinsey + GSK Vaccines + Synosia + Syngenta) |
Chief Business Officer (CBO) |
CureVac (Group) |
Germany |
| Blank, Michael (Verve Capital Partners 201807 Investment Manager) |
Investment Manager |
Verve Capital Partners AG (Verve Ventures, formerly investiere.ch) |
Switzerland |
| Blank, Wolfgang (BioCon Valley 201103 Managing Director) |
Managing Director |
BioCon Valley GmbH |
Germany |
| Blanke, Gernot (Blanke Meier Evers + Kompass Private Equity) |
n. a. |
Blanke Meier Evers |
Germany |
| Blankenburg, Axel (Euroimmun 201207 CFO) |
Chief Financial Officer (CFO) |
PerkinElmer (Group) |
Germany |
| Blankenship, Kyle (BeiGene 202207 Media Relations) |
Public Relations Manager / Investor Relations Manager |
BeiGene (Group) |
United States (USA) |
| Blankenstein, Thomas (Helmholtz 202008 Prof at MDC Berlin + Co-Founder of T-Knife GmbH) |
Professor |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Blasco, María (CNIO 201312 Director) |
President/Director/Head Business Group/Unit/Division |
CNIO (Centro Nacional de Investigaciones Oncológicas) |
Spain (España) |
| Blasczyk, Rainer (MHH 202409 Professor + Director of ITT + Co-Founder of Allogenetics) |
Professor |
MHH (Hanover Medical School / Medizinische Hochschule Hannover) |
Germany |
| Blatter, Joachim (Basilea 201201– CFO before Swissmetal Industries) |
Chief Financial Officer (CFO) |
Basilea (Group) |
Switzerland |
| Blaukat, Andree (Merck (DE) 201312 Head Translational Innovation Platform Oncology at Merck Serono) |
Research & Development Manager |
Merck (DE) (Group) |
Germany |
| Blaurock-Möller, Nancy (PR Management + Co-Founder) |
Public Relations Manager / Investor Relations Manager |
Dynamic42 GmbH |
Germany |
| Blavier, André (Interactive Biosoftware 201211 CEO + Founder) |
Chief Executive Officer (CEO) |
Sophia Genetics (Group) |
France |
| Bléhaut, Jean (Novasep 201509 Chief Innovation Officer) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Novasep (Group) |
France |
| Bleiholder, Christian (Florida State Univ 201606 Professor at Dept of Chemistry + Biochemistry) |
Professor |
Florida State University (FSU) |
United States (USA) |
| Bleile, Bernd (Curetis 201602– in-house Legal Counsel) |
Legal Manager |
OpGen (Group) |
Germany |
| Blind, Michael (NascaCell 200809 CEO) |
Chief Executive Officer (CEO) |
NascaCell (Group) |
Germany |
| Block, Christoph (Signalomics 200604–201307 CEO LEFT 7/13) |
Chief Executive Officer (CEO) |
Signalomics GmbH |
Germany |
| Blome, James A. (Jim) (Cellectis 201810– CEO of Calyxt Inc before Bayer CropScience LP + Valent + Agrliance) |
Chief Executive Officer (CEO) |
Cellectis (Group) |
United States (USA) |
| Bloom, Kenneth (General Electric 201402 CMO of Clarient Diagnostics Services Inc) |
Chief Medical Officer (CMO) |
General Electric (Group) |
United States (USA) |
| Bloom-Baglin, Rachel (Merck (DE) 202206) |
Public Relations Manager / Investor Relations Manager |
MilliporeSigma (business unit of Merck KGaA) |
United States (USA) |
| Bloomfield, Mark (Polyplus-transfection 201004– CEO before ABI + Thermo Electron + Agilent + HP) |
Chief Executive Officer (CEO) |
Sartorius (Group) |
France |
| Bluestein, Scott (Hercules Technology 201812 Chief Investment Officer at Hercules Capital) |
Investment Manager |
Hercules Capital (HTGC) (Group) |
United States (USA) |
| Bluestone, Jeffrey (Jeff) (Sonoma Biotherapeutics 202002 CEO + Co-Founder former CEO + President of Parker Institute) |
Chief Executive Officer (CEO) |
Sonoma Biotherapeutics Inc. |
United States (USA) |
| Blum, Nora (Selfapy 202302 Managing Director + Co-Founder) |
Managing Director |
Selfapy GmbH |
Germany |
| Blumenthal, Ralf (Qiagen 200610 Associate Director BusDev) |
Business Development Manager / Strategy Manager |
Qiagen (Group) |
Germany |
| Blunier, Heinz (Febit 200901– COO before Inventa + Tegimenta + Boehringer Mannheim) |
Chief Operating Officer (COO) |
febit (Group) |
Germany |
| Blöcker, Helmut |
n. a. |
Humangenomprojekt (DE) |
Germany |
| Blöndal, Arni (Brunnur Ventures 201810) |
Investment Manager |
Brunnur Ventures |
Iceland |
| Boada, Gonzalo (Andera Partners 202411– Director at MidCap team based in Madrid before H.I.G. Capital) |
Investment Manager |
Andera Partners (FR) |
Spain (España) |
| Bobbert, Cornelius |
n. a. |
Kuhnen & Wacker Patent- und Rechtsanwaltsbüro |
Germany |
| Bocci, Marco (Selexis 201311– Director European Sales + Business Development before Quintiles) |
Sales Manager / Marketing Manager |
JSR Corporation (Group) |
Switzerland |
| Boch, Gary (CEVEC Pharmaceuticals 201011 VP BusDev + Head US Business) |
Chief Commercial Officer (CCO) |
Danaher (Group) |
United States (USA) |
| Bochow, Albrecht (GPS Ventures 202012 General Partner) |
General Partner (venture partner) |
GPS Ventures GmbH |
Germany |
| Bochtler, Hans Joachim (MediGene 200809– Head RnD before Fresenius Biotech) |
Research & Development Manager |
Medigene (Group) |
Germany |
| Bock, Holger (Ugichem 201108 Managing Director CEO + founder) |
Managing Director |
Ugichem Gesellschaft für organische Chemie mbH |
Austria |
| Bock, Maximilian (High-Tech Gründerfonds 202108 Investment Manager) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Bock, Olaf (Wulf Group 202111 Managing Director of zwei.7 Equity GmbH) |
Managing Director |
WULF Group (family of Karsten Wulf / zwei.7) |
Germany |
| Bode, Jörg (Niedersachsen (govt) 200912 Minister of Economic Affairs, Labour and Transport) |
Minister |
Niedersachsen (govt region) |
Germany |
| Bode, Tim (Business Angel) |
n. a. |
PERSON |
|
| Bodenmiller, Bernd (Univ Zurich 201710 Assistant Professor) |
Professor |
University of Zurich (UZH) |
Switzerland |
| Bodenstedt, Matthias (MoonLake 202107– CFO before McKinsey) |
Chief Financial Officer (CFO) |
MoonLake Immunotherapeutics (Group) |
Switzerland |
| Bodiselitsch, Bernd (Imprint Analytics 201812 Managing Director) |
Managing Director |
Imprint Analytics GmbH |
Austria |
| Bodson, Bertrand (Novartis 201801– Chief Digital Officer before Sainsbury’s Argos + EMI + Amazon + Boston Consulting) |
Chief Information Officer (CIO) / Chief Digital Officer |
Novartis (Group) |
Switzerland |
| Boehler, Michael (BioNTech 201905 Head of Global External Communications) |
Public Relations Manager / Investor Relations Manager |
BioNTech (Group) |
Germany |
| Boehm, Dr. (Heidelberg Pharma 200610 Chief Development Officer) |
Research & Development Manager |
Heidelberg Pharma (Group) |
Germany |
| Boehm, Rainer (Cellectis 201706– Board Member before 29y at Novartis) |
Board member, non-executive |
Cellectis (Group) |
France |
| Boehnlein, Ernst (NascaCell 200708 CEO) |
Chief Executive Officer (CEO) |
NascaCell (Group) |
Germany |
| Boehringer, Christian (Boehringer 201207 Chairman of Shareholders’ Committee) |
Board member, non-executive |
Boehringer Ingelheim (Group) |
Germany |
| Boehringer, Christoph (Mediatum 2001– Managing Director + CD-Venture 2003– Managing Director + co-owner Boehringer) |
Managing Director |
Mediatum (Group) |
Germany |
| Boehringer, Mathias Albert (Boehringer 200809 Gesellschafterausschuss) |
n. a. |
Boehringer Ingelheim (Group) |
Germany |
| Boël, Harold (Sofina 202109 CEO) |
Chief Executive Officer (CEO) |
|
|
| Boeltz, Harry (Dispendix 201812 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Bico (Group) |
Germany |
| Boesen, Jan (IBL International GmbH 201407 Managing Director) |
Managing Director |
Tecan (Group) |
Germany |
| Boesl-von Grafenstein, Ulrich (TU München 201007 Professor Physical Chemistry) |
Professor |
Technical University Munich (TU München, TUM) |
Germany |
| Boettiger, Sara (Bayer 202009– Head Crop Science Global Affairs + Science + Sustainability before McKinsey + Gates) |
Public Relations Manager / Investor Relations Manager |
Bayer (Group) |
Germany |
| Bogenstätter, Michael (Germany (govt) 201707 German Accelerator Life Sciences) |
n. a. |
Start2 Group (Group) |
United States (USA) |
| Boghossian, John (Quercis Pharma 202104– CEO before VP of Operations at Compass Pathways + Boston Consulting) |
Chief Executive Officer (CEO) |
Quercis Pharma (Group) |
Switzerland |
| Bogsch, Erik (Gedeon Richter 19982– CEO joined 1970) |
Chief Executive Officer (CEO) |
Gedeon Richter (Group) |
Hungary |
| Bogsch, Erik [2] (Gedeon Richter 201405 Deputy Director Biotechnology) |
President/Director/Head Business Group/Unit/Division |
Gedeon Richter (Group) |
Hungary |
| Bohen, Sean (AstraZeneca 201509– EVP Global Medicines Developent + CMO before Genentech + Stanford Univ) |
Chief Medical Officer (CMO) |
AstraZeneca (Group) |
United Kingdom (GB) |
| Bohlen, Heribert (Axiogenesis 201603 CEO) |
Chief Executive Officer (CEO) |
Evotec (Group) |
Germany |
| Bohm, Katarina (Promega 201411 Head of Marketing at Promega GmbH) |
Sales Manager / Marketing Manager |
Promega (Group) |
Germany |
| Bohmann, Armin (Bohmann & Loosen 200809) |
n. a. |
Bohmann & Loosen (Munich) |
Germany |
| Bohn, Thomas |
n. a. |
febit (Group) |
Germany |
| Boidol, Bernhard (Bernd) (Proxygen 202012 CEO) |
Chief Executive Officer (CEO) |
Proxygen GmbH |
Austria |
| Bois, Sabine (SAW Instruments 2010– Managing Director Head Finance + co-founder) |
Managing Director |
NanoTemper (Group) |
Germany |
| Boissel, Stéphane (SparingVision 202010– CEO before Sangamo + TxCell + Genclis + Transgene + Innate Pharma + Lazard) |
Chief Executive Officer (CEO) |
SparingVision SAS |
France |
| Bold, Markus (BASF 202005 Managing Director of Chemovator GmbH) |
Managing Director |
BASF (Group) |
Germany |
| Boldt, Grant (CPTx 202409 COO former head of biologics at Lonza) |
Chief Operating Officer (COO) |
CPTx GmbH |
Germany |
| Boles, Eckhard (Univ Frankfurt 201404 Professor + Head of Institute of Physiology + Genetics of Lower Eukaryotes) |
Professor |
University of Frankfurt (Goethe-Universität) |
Germany |
| Boll, Björn (Ten23 Health 202305 Senior Director for Particle Characterization + Drug Product Design) |
n. a. |
Ten23 Health AG |
Switzerland |
| Bolliger, Luca (Novimmune 201012 Director Business Development + Communication) |
Company Founder |
abcDNA GmbH |
Switzerland |
| Bollineni, Ravi Chand (Univ Leipzig 201106 Workin Group Bioanalytics) |
Researcher (university / research institute) |
University of Leipzig |
Germany |
| Bollmann, Magdolna (IMoGen GmbH 201104 Managing Director) |
Managing Director |
IMogen Institut für Molekularpathologie und Gendiagnostik GmbH |
Germany |
| Bolzon, Bradley (Brad) (Versant Ventures 200701 Managing Director) |
Managing Director |
Versant Ventures |
United States (USA) |
| Bond, Colin (Vifor Pharma 201707 CFO before Evotec 201008–201606 CFO LEFT 6/16) |
Chief Financial Officer (CFO) |
Vifor Pharma (Group) |
Switzerland |
| Bonde, Martin (Vaccibody 201508– CEO before EpiTherapeutics ApS + Aros Pharma ApS + Natimmune AS + Combio AS) |
Chief Executive Officer (CEO) |
Vaccibody AS (Euronext Growth Oslo: VACC) |
Norway |
| Bonenberger, Michael (MCH Group 201807 Exhibition Director ILMAC) |
Event Manager / Conference Manager |
MCH Group AG |
Switzerland |
| Bonert, Christian (ipOcean Global GmbH 202004 Managing Director) |
Managing Director |
ipOcean Global GmbH |
Germany |
| Bongaerts, Sabine (Bayer 201605 Head of Drug Discovery Animal Health) |
President/Director/Head Business Group/Unit/Division |
Elanco (Group) |
Germany |
| Bonham-Carter, John (Refine Technology 201201 VP Sales + Business Development) |
Sales Manager / Marketing Manager |
Refine Technology LLC |
United States (USA) |
| Bonifacio, Ezio (TU Dresden 201712 Director of CRTD) |
Professor |
Technical University Dresden (TU Dresden) |
Germany |
| Bonin, Michael (IMGM Laboratories GmbH 201408– Managing Director before Univ Tübingen Director of MFTServices) |
Managing Director |
IMGM Laboratories GmbH |
Germany |
| Bonn, Günther (Univ Innsbruck 201211 Professor + Scientific Director at ADSI) |
Professor |
University of Innsbruck |
Austria |
| Bonnet, Frank (Bionomous 202208 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Bionomous S.A. |
Switzerland |
| Bonnet, Lucille (High-Tech Gründerfonds 201604 Investment Manager) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Bonneville, Christophe (Resolution Spectra Systems 202007 President + Co-Founder) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
France |
| Bonny, Christophe (Enterome 201609– CSO before Bicycle Therapeutics + Xigen + Univ Hospital Lausanne) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Enterome S.A. |
France |
| Bonvicini, Paola (Helsinn 201705 Group Head of Communication) |
Public Relations Manager / Investor Relations Manager |
Helsinn (Group) |
Switzerland |
| Boomgaarden, Wolfgang (PharmaInformatic 200509 founder) |
n. a. |
PharmaInformatic Boomgaarden |
Germany |
| Boorsma, Marco (Forbion Capital Partners 201302) |
Partner (venture partner) |
Forbion (Group) |
Netherlands |
| Boos, Andreas (Curetis 200812– Managing Director) |
Managing Director |
OpGen (Group) |
Germany |
| Boos, Erwin (Schroders 201709 Schroder Adveq) |
Investment Manager |
Schroders (Group) |
Switzerland |
| Boosfeld, Jochen (Bruker 200809 Bruker Daltonik GmbH) |
Sales Manager / Marketing Manager |
Bruker (Group) |
Germany |
| Boot, Harry (Lonza 201103–201205 COO Life Science Ingredients sector before Bluestar/Blackstone + GE) |
Chief Operating Officer (COO) |
Lonza (Group) |
Switzerland |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 7 8 9 ... 93 94 95 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
